Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program

Idilman, R.Demir, M.Aladag, M.Kaymakoglu, S.Erol, C.Cavus, B.Iliaz, R.Akarca, U. S.Koklu, S.Cakaloglu, Y.Sahin, M.Koksal, I.Ozgenel, M.Toka, B.Karasu, Z.Ersoz, G.Kiyici, M.Akdogan, M.Turkey, E. A. P.2019-10-272019-10-2720180168-82781600-0641https://hdl.handle.net/11454/30467International Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCEeninfo:eu-repo/semantics/closedAccessRecurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access programConference Object68S301S301WOS:000461068601213Q1